Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Michigan State University
- Study ID
- NCT06232304
- Status
- Recruiting
Conditions
- Systemic Lupus Erythematosus of Childhood (Disorder)
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - 22 Years
- Healthy Volunteers
- Not accepted
Interventions
- TEACH — BEHAVIORALTEACH is a cognitive behavioral coping skills program. It consists of six one-hour weekly sessions that are conducted either in-person or remotely.
Study Details
This study aims to investigate the feasibility and effectiveness of a cognitive behavioral coping skills program, Treatment and Education Approach for Childhood-onset Lupus (TEACH), for youth with cSLE when integrated into medical care. This TEACH program aims to teach participants skills in order to cope with fatigue, pain, and depressive symptoms--symptoms that commonly affect adolescents and young adults with lupus.
Key Dates
- Start date
- Sep 12, 2024
- Status verified
- Oct 2025
- Primary completion
- Apr 1, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 175 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: TEACHParticipants will undergo a cognitive behavioral coping skills program and continue medical treatment as usual.
- No Intervention: ControlParticipants will only continue medical treatment as usual.
Primary Outcome Measure
Depressive symptoms, as measured by the Children's Depression Inventory-2 (CDI-2) and Beck Depression Inventory-II (BDI-II) (primary) [ Time Frame: T1 (baseline), T2 (8 weeks), T3 (20 weeks), T4 (32 weeks), T5 (44 weeks), T6 (56 weeks) ]
Central Contacts
- Jocelyn S Zuckerman, BA9785051866
- Natoshia R Cunningham, PhD845-662-6198
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama Birmingham Hospital | Birmingham | Alabama | 35233 | Dr. Emily Smitherman (PRINCIPAL_INVESTIGATOR) |
| Children's Hospital of New Orleans/ Tulane University | New Orleans | Louisiana | 70118 | Dr. Anita Dhanrajani (PRINCIPAL_INVESTIGATOR) |
| Helen Devos Children's Hospital | Grand Rapids | Michigan | 49503 | Dr. Kessler (PRINCIPAL_INVESTIGATOR) |
| Montefiore Medical Center | The Bronx | New York | 10467 | Dr. Tamar Rubinstein (PRINCIPAL_INVESTIGATOR) |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | Dr. Ekemini Ogbu (PRINCIPAL_INVESTIGATOR) |
| Seattle Children's Hospital | Seattle | Washington | 98105 | Dr. Rosenwasser (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Birmingham, AL
By research site
University of Alabama Birmingham Hospital· Birmingham, ALChildren's Hospital of New Orleans/ Tulane University· New Orleans, LAHelen Devos Children's Hospital· Grand Rapids, MIMontefiore Medical Center· The Bronx, NYCincinnati Children's Hospital Medical Center· Cincinnati, OHSeattle Children's Hospital· Seattle, WA